TEFASRisk 7/7Price Nov 2, 2026
Hedef Portföy Güneş Hisse Senedi Serbest (TL) Fon (Hisse Senedi Yoğun Fon) HGH
- Fund size (Nov 2, 2026)
- TRY 96.8K
- Investors
- 19
- Management fee (annual)
- 0.90%
The Capital Markets Board (SPK) decided to liquidate this fund in bulletin 2026/60 dated September 17, 2026; the liquidation list was updated by bulletin 2026/61. No buy or redemption orders are executed in the fund; no live estimate is produced. Prices and returns are based on the last price published on TEFAS (November 2, 2026). SPK bulletin 2026/60 · List of funds in liquidation
At a Glance: HGH Fund
- The HGH fund is on the liquidation list of Capital Markets Board (SPK) bulletin 2026/60 dated September 17, 2026. Liquidated funds
- According to Yatırımcı.AI data, the last official price of the HGH fund was TRY 0.169157 (November 2, 2026); no buy or redemption orders are executed.
- The HGH fund returned −90.18% over 1 month, −89.42% year to date and −90.41% over 1 year.
- The HGH fund has total assets of TRY 96.8K and 19 investors.
- The HGH fund is in the Hedge Fund category, with a CMB (SPK) risk score of 7 out of 7.
- The HGH fund was established by Hedef Portföy Yönetimi A.Ş.
What is the HGH fund?
HGH is the fund code of Hedef Portföy Güneş Hisse Senedi Serbest (TL) Fon. It was established by Hedef Portföy Yönetimi A.Ş. The HGH fund is in the Hedge Fund category, with a CMB (SPK) risk score of 7 out of 7. The fund is in liquidation by Capital Markets Board (SPK) decision.
What is the HGH fund price and return?
The last official price of the HGH fund was TRY 0.169157 (November 2, 2026). It returned −90.18% over 1 month, −89.42% year to date and −90.41% over 1 year.
Is the HGH fund being liquidated?
Yes. The HGH fund is on the liquidation list of Capital Markets Board (SPK) bulletin 2026/60 dated September 17, 2026; no buy or redemption orders are executed. All liquidated funds are listed on the Yatırımcı.AI liquidated funds page.
HGH Fund Price Chart
Key Data
- Price
- 0.169157Nov 2, 2026
- Daily change
- −14.61%
- Trading status
- In liquidation
- Category
- Hedge Fund
- Umbrella fund
- Hedge
- Manager
- Hedef Portföy Yönetimi A.Ş.
- Risk score
- 7 / 7
- Fund size
- TRY 96.8KNov 2, 2026
- Investors
- 19
- Units outstanding
- 572.4K
- ISIN
- TRYHDFP00409
- Inception date
- Nov 30, 2022
- Benchmark
- %100 BIST-KYD 1 Aylık Mevduat TL Endeksi
HGH Return Comparison
| Comparison | 1M | 3M | 6M | YTD | 1Y |
|---|---|---|---|---|---|
| HGH | −90.18% | −90.27% | −90.42% | −89.42% | −90.41% |
| Category average | 1.91% | 4.46% | 10.24% | 18.46% | 22.63% |
| BIST 100 | −11.29% | −19.10% | −24.61% | −3.34% | −0.78% |
| Category rank | 324 / 324 | 324 / 324 | 324 / 324 | 323 / 324 | 301 / 302 |
Returns are calculated from the last price published on TEFAS (November 2, 2026). The amount paid to investors in liquidation depends on the cash raised from selling the portfolio and may differ from these returns.
HGH Fund Review and Performance Summary
HGH returned −90.41% over the last year, ranking 301 of 302 funds in the Hedge Fund category. Over the same period: category average 22.63%, BIST 100 −0.78%.
Between November 3, 2025 and November 2, 2026 the unit price ranged from a low of TRY 0.169157 (November 2, 2026) to a high of TRY 1.991820 (June 25, 2026). The latest price is at the low of the period.
The largest decline in the period was 91.51% (from the June 25, 2026 high to November 2, 2026). Annualized volatility based on daily price changes: 201.15%. The price rose on 106 of 249 trading days.
Monthly returns were positive in 6 of the last 12 months; best month April 2026 (9.90%), weakest month October 2026 (−88.51%).
Between November 3, 2025 and November 2, 2026 the number of investors fell 38.71%, from 31 to 19. Fund size fell from TRY 94.2M to TRY 96.8K over the same period.
Highest one-year returns in the category: BSM (88.67%), RBR (70.72%), GZM (67.43%).
HGH monthly returns
| Month | Month-end price (TRY) | Monthly return |
|---|---|---|
| October 2026 | 0.198107 | −88.51% |
| September 2026 | 1.724083 | −4.42% |
| August 2026 | 1.803864 | 5.30% |
| July 2026 | 1.713137 | −10.94% |
| June 2026 | 1.923643 | 4.77% |
| May 2026 | 1.836035 | 3.94% |
| April 2026 | 1.766483 | 9.90% |
| March 2026 | 1.607347 | −6.12% |
| February 2026 | 1.712039 | −1.56% |
| January 2026 | 1.739254 | 8.80% |
| December 2025 | 1.598554 | 0.77% |
| November 2025 | 1.586352 | −8.10% |
This summary is calculated automatically from TEFAS price history and category data; it is not investment advice. Past performance does not indicate future returns.
Add HGH to your watchlist
Follow this fund and the other funds you hold in one list with a free account.
- Follow funds and stocks in one watchlist
HGH Asset Allocation
- Deposits (TL)100.00%
HGH Largest Holdings
Net Flows
Investors
Similar Funds
| Fund | 1 month | YTD | 1 year |
|---|---|---|---|
 FSPFonmap Portföy Serbest (Döviz) Fon | −33.71% | −72.04% | −71.27% |
 SHUSparta Portföy Üçüncü Hisse Senedi Serbest (TL) Fon | −16.22% | −11.11% | — |
 KLSAllbatross Portföy Katılım Serbest (Döviz) Fon | −3.53% | −6.14% | −3.91% |
 BRCRe-Pie Portföy Birinci İstatistiksel Arbitraj Hisse Senedi Serbest Fon | −20.46% | −4.39% | −0.67% |
| RGHRe-Pie Portföy Mutlak Getiri Hedefli Hisse Senedi Serbest Fon | −29.73% | −19.29% | — |
Related Pages
About the HGH Fund
SPK decided to liquidate HGH in bulletin 2026/60 dated September 17, 2026; the liquidation list was updated by bulletin 2026/61. No buy or redemption orders are executed in the fund. Last price published on TEFAS (November 2, 2026): TRY 0.169157. Hedef Portföy Güneş Hisse Senedi Serbest (TL) Fon (Hisse Senedi Yoğun Fon) is a mutual fund in the Hedge Fund category founded by Hedef Portföy Yönetimi A.Ş. Fund size TRY 96.8K as of November 2, 2026, 19 investors.
Ekonomik ve finansal piyasaları etkileyen diğer faktörlerin analizi ve beklentilere göre oluşacak yatırım öngörüsü doğrultusunda TL cinsi para ve sermaye piyasası araçlarına, taraf olunacak sözleşmelere, finansal işlemlere ve menkul kıymetlere ve Kurulca uygun görülen diğer yatırım araçlarına yatırım yaparak sermaye kazancı ve faiz geliri sağlamak ve portföy değerini artırmayı amaçlamaktadır. Bu doğrultuda temel ve teknik analiz yöntemleri kullanılarak fiyatı yükselmesi beklenen varlıklara yatırım yapılarak gelir yaratmaya çalışılacaktır.
Last updated: Source: TEFAS
Frequently Asked Questions
Is the HGH fund open to trading?
SPK decided to liquidate HGH in bulletin 2026/60 dated September 17, 2026; the liquidation list was updated by bulletin 2026/61. No buy or redemption orders are executed in the fund. The last price published on TEFAS is TRY 0.169157 as of November 2, 2026.
When was the last price of HGH published?
The last official unit price of HGH is TRY 0.169157 as of November 2, 2026. Returns on this page are calculated from this price.
What does fund liquidation mean?
Liquidation means the assets in the fund portfolio are sold, the cash raised is transferred to investors in proportion to their units and the fund is wound up. Under SPK bulletin 2026/61, T.C. Ziraat Bankası A.Ş. carries out the liquidation of HGH. The maximum liquidation period of 3 months set in 2026/61 was extended to 6 months by bulletin 2026/62; the period runs from the liquidation announcement date and the Board may extend it.
How much did HGH return over the last year?
Based on the last price published on TEFAS (November 2, 2026), HGH returned −90.41% over the last year, −89.42% year to date, −90.27% over 3 months and −90.18% over 1 month. Past performance does not indicate future returns.
What were the highest and lowest prices of HGH over the last year?
Between November 3, 2025 and November 2, 2026 the unit price of HGH ranged from a low of TRY 0.169157 (November 2, 2026) to a high of TRY 1.991820 (June 25, 2026). The latest price as of November 2, 2026 is TRY 0.169157.
What is the risk score of HGH?
The CMB risk score of HGH is 7 out of 7. The score reflects the historical volatility of the fund price; 1 is the lowest and 7 the highest risk.
What does HGH invest in?
The portfolio of HGH consists mainly of Deposits (TL) (100.00%). Ekonomik ve finansal piyasaları etkileyen diğer faktörlerin analizi ve beklentilere göre oluşacak yatırım öngörüsü doğrultusunda TL cinsi para ve sermaye piyasası araçlarına, taraf olunacak sözleşmelere, finansal işlemlere ve menkul kıymetlere ve Kurulca uygun görülen diğer yatırım araçlarına yatırım yaparak sermaye kazancı ve faiz geliri sağlamak ve portföy değerini artırmayı amaçlamaktadır. Bu doğrultuda temel ve teknik analiz yöntemleri kullanılarak fiyatı yükselmesi beklenen varlıklara yatırım yapılarak gelir yaratmaya çalışılacaktır.
Which other funds are in the same category as HGH?
HGH belongs to the Hedge Fund category. Compare the returns of all funds in the category on the category page and the overall ranking on the best funds page.